Message Containing Symbol KWBT (Kiwa Bio-tech Products Group Corp.)

>  >  >   spam works: evidence from stock touts and corresponding market activity

View this message on its own page

Jump to the first occurrence of the symbol

Jump to the index of occurrences of this symbol

Clicking on a highlighted symbol will jump to the next highlighted occurrence of the symbol.


-+-+-+- NEXT SEGMENT -+-+-+-
Segment of length 9226
From redacted@cybernothing.org Thu Jul 01 08:00:36 2004
Return-Path: <redacted@peru.com>
Received: from localhost by nelson with LMTP; Thu, 01 Jul 2004 01:06:39 -0400
Received: from ralph.harvard.edu (ralph.harvard.edu [128.103.149.85])
by nelson.harvard.edu (Switch-3.1.3/Switch-3.1.0) with SMTP id i6156do7005282;
Thu, 1 Jul 2004 01:06:39 -0400 (EDT)
Received: from camail.harvard.edu ([127.0.0.1])
by ralph.harvard.edu (SAVSMTP 3.1.6.45) with SMTP id M2004070101063805327
; Thu, 01 Jul 2004 01:06:38 -0400
Received: from ralph (localhost [127.0.0.1])
by camail.harvard.edu (Postfix) with SMTP;
Thu, 1 Jul 2004 01:06:39 -0400 (EDT)
Received: from lenny.harvard.edu (lenny.harvard.edu [128.103.56.198])
by camail.harvard.edu (Postfix) with ESMTP id 586935E;
Thu, 1 Jul 2004 01:06:35 -0400 (EDT)
Received: from 128.103.56.198 (unknown [211.228.78.171])
by lenny.harvard.edu (Postfix) with SMTP id B71101766;
Thu, 1 Jul 2004 01:06:32 -0400 (EDT)
X-Message-Info: p36VRH1fs6E76JJDBOlhW9ndbU1dtoHQfXY15PHM7
Received: (from redacted@211.228.78.171)
by oust8.24.156.208.48 (7.55.8/9.97.3) id z07LXbV39170;
Thu, 01 Jul 2004 04:11:19 +0100
Message-ID: <redacted@dkdsmk@peru.com>
Reply-To: "Lucille " <redacted@peru.com>
From: "Lucille " <redacted@peru.com>
To: "Zittrain" <redacted@law.harvard.edu>
Subject: [POSSIBLE SPAM] KWBT is About To Make a Move
Date: Thu, 01 Jul 2004 06:07:19 +0300
MIME-Version: 1.0
Content-Type: multipart/alternative;
boundary="--33372848591082034"
X-Spam-Flag: YES
X-Spam-Checker-Version: SpamAssassin 2.63-soc_rev_22 (2004-01-11) on ralph
X-Spam-Level: ****************
X-Spam-Status: Yes, hits=16.1 required=4.0 autolearn=no
version=2.63-soc_rev_22

OUR LAST PICK
*************************************************************************
Congratulations to all investors who took advantage of our last Stock
Pick!!!

GRYW - The stock was initially profiled at .40 cents and reached $1.80
in two weeks.

The situation with our new stock pick is similar so act now to get in
on the move!
*************************************************************************

++ Major Trading Alert : Late breaking news...++

******Investors have not yet had the opportunity to trade on this
information.******

After the close of trading on Friday, Kiwa biotech announced...

Three Orders in Q2 Represent an aggregate 700% Increase from
Distributors Previous Orders in Dollar Terms

LOS ANGELES, June 25, 2004 (PRIMEZONE) -- Kiwa Bio-Tech Products Group
Corporation (``the Company'' or ``KIWA'') (OTC BB:KWBT) announced today
that a China-based distributor of its products has placed its third
order this quarter, which represents a significant increase over the
previous order by this repeat customer. Entering Q2, the distributor placed
three orders which total 7 times the size of the order placed by this
customer in Q1.

******Investors have not yet had the opportunity to trade on this
information.******

The hottest stock Today - Watch KWBT

We expect some strong demand for this stock in the near future!!!!!

The Stock is EXTREMELY TIGHT - The float is only 4M shares!!!

Get on Board now and enjoy some great profits with KWBT

CURRENT PRICE - $.32

SPECULATIVE NEAR TERM TARGET PRICE - $.80
SPECULATIVE LONG TERM TARGET PRICE - $1.85

KWBT* KWBT* KWBT* KWBT* KWBT* KWBT* KWBT* KWBT* KWBT* KWBT * KWBT

About the Company:
------------------------------------------------------------------------
Based in the City of Industry, California, with manufacturing centers
in mainland China, KIWA Bio-Tech Products Group Corporation is a public
company (OTCBB: KWBT) that develops, manufactures and distributes
innovative, cost-effective, and environmentally-safe biotechnology products
to agricultural markets. The company is a pioneer in commercialization
of biotechnology, having a manufacturing base in Shandong Province,
China and plans to distribute bio-tech products worldwide.

With 20 years of research and development experience in biotechnology,
KIWA's patented products are produced through a cost-effective
manufacturing process. KIWA's first marketplace entry is Mainland China, with
an American presence planned by 2005. With approval and subsidies from
the Chinese government, KIWA has established a manufacturing center
which is a well developed distribution point for the world's most
populated country.

The Market:
-------------------------------------------------------------------------
KIWA Bio-Tech recognized early the dire need in mainland China for
affordable, easy-to-use organic agricultural products, as well as the
difficulties in distributing their products to farmers in the world's most
populous country. With over 1.3 billion people, China possesses 7% of
the world's agricultural land but supports 20% of the world's
population. With these demands the strain on arable land in China is enormous.
Overuse of chemical herbicides and insecticides hold the potential to
destroy the limited water supply of China, making organic compounds an
obvious alternative.

With China's underdeveloped farm communities, KIWA strives to provide
the average local farmer with the ability to grow higher quality produce
and greater crop yields. Agribusiness is 14% of China's Gross Domestic
Product, totaling as much as $180 billion in 2002 alone. With this type
of market potential, China was an obvious first choice for KIWA's
full-scale entry into the "Agri-Bio" marketplace. In the coming year an
entrance into the American agricultural market is planned, but KIWA will
establish the immense value of their product in Chinese agribusiness
first.

-------------------------------------------------------
We wish you profitable trading!!

---------------
Disclaimer
---------------
Information within this email contains "forward looking statements"
within the meaning of Section 27A of the Securities Act of 1933 and
Section 21B of the Securities Exchange Act of 1934. Any statements that
express or involve discussions with respect to predictions, goals,
expectations, beliefs, plans, projections, objectives, assumptions or future
events or performance are not statements of historical fact and may be
"forward looking statements."

Forward looking statements are based on expectations, estimates and
projections at the time the statements are made that involve a number of
risks and uncertainties which could cause actual results or events to
differ materially from those presently anticipated. Forward looking
statements in this action may be identified through the use of words such
as: "projects", "foresee", "expects", "estimates," "believes,"
"understands" "will," "part of: "anticipates," or that by statements indicating
certain actions "may," "could," or "might" occur. All information
provided within this email pertaining to investing, stocks, securities must
be understood as information provided and not investment advice.
Emerging Equity Alert advises all readers and subscribers to seek advice from
a registered professional securities representative before deciding to
trade in stocks featured within this email. None of the material within
this report shall be construed as any kind of investment advice. Please
have in mind that the inter retation of the writer of this newsletter
about the news published by the company does not represent the company
official statement and in fact may differ from the real meaning of what
the news release meant to say. Please read the news release by yourself
and judge by yourself about the details in it.

In compliance with Section 17(b), we disclose the holding of KWBT
shares prior to the publication of this report. Be aware of an inherent
conflict of interest resulting from such holdings due to our intent to
profit from the liquidation of these shares. Shares may be sold at any
time, even after positive statements have been made regarding the above
company. Since we own shares, there is an inherent conflict of interest in
our statements and opinions. Readers of this publication are cautioned
not to place undue reliance on forward-looking statements, which are
based on certain assumptions and expectations involving various risks and
uncertainties, that could cause results to differ materially from those
set forth in the forward- looking statements.

Please be advised that nothing within this email shall constitute a
solicitation or an offer to buy or sell any security mentioned herein.
This newsletter is neither a registered investment advisor nor affiliated
with any broker or dealer. All statements made are our express opinion
only and should be treated as such. We may own, buy and sell any
securities mentioned at any time. This report includes forward-looking
statements within the meaning of The Private Securities Litigation Reform Act
of 1995. These statements may include terms as "expect", "believe",
"may", "will", "move", "undervalued" and "intend" or similar terms. This
newsletter was paid $3,500 from third party to send this report. PLEASE
DO YOUR OWN DUE DILIGENCE BEFORE INVESTING IN ANY PROFILED COMPANY. You
may lose money from investing in Penny Stocks.

-+-+-+- NEXT SEGMENT -+-+-+-
Segment of length 9226
From redacted@cybernothing.org Thu Jul 01 08:00:36 2004
Return-Path: <redacted@peru.com>
Received: from localhost by nelson with LMTP; Thu, 01 Jul 2004 01:06:39 -0400
Received: from ralph.harvard.edu (ralph.harvard.edu [128.103.149.85])
by nelson.harvard.edu (Switch-3.1.3/Switch-3.1.0) with SMTP id i6156do7005282;
Thu, 1 Jul 2004 01:06:39 -0400 (EDT)
Received: from camail.harvard.edu ([127.0.0.1])
by ralph.harvard.edu (SAVSMTP 3.1.6.45) with SMTP id M2004070101063805327
; Thu, 01 Jul 2004 01:06:38 -0400
Received: from ralph (localhost [127.0.0.1])
by camail.harvard.edu (Postfix) with SMTP;
Thu, 1 Jul 2004 01:06:39 -0400 (EDT)
Received: from lenny.harvard.edu (lenny.harvard.edu [128.103.56.198])
by camail.harvard.edu (Postfix) with ESMTP id 586935E;
Thu, 1 Jul 2004 01:06:35 -0400 (EDT)
Received: from 128.103.56.198 (unknown [211.228.78.171])
by lenny.harvard.edu (Postfix) with SMTP id B71101766;
Thu, 1 Jul 2004 01:06:32 -0400 (EDT)
X-Message-Info: p36VRH1fs6E76JJDBOlhW9ndbU1dtoHQfXY15PHM7
Received: (from redacted@211.228.78.171)
by oust8.24.156.208.48 (7.55.8/9.97.3) id z07LXbV39170;
Thu, 01 Jul 2004 04:11:19 +0100
Message-ID: <redacted@dkdsmk@peru.com>
Reply-To: "Lucille " <redacted@peru.com>
From: "Lucille " <redacted@peru.com>
To: "Zittrain" <redacted@law.harvard.edu>
Subject: [POSSIBLE SPAM] KWBT is About To Make a Move
Date: Thu, 01 Jul 2004 06:07:19 +0300
MIME-Version: 1.0
Content-Type: multipart/alternative;
boundary="--33372848591082034"
X-Spam-Flag: YES
X-Spam-Checker-Version: SpamAssassin 2.63-soc_rev_22 (2004-01-11) on ralph
X-Spam-Level: ****************
X-Spam-Status: Yes, hits=16.1 required=4.0 autolearn=no
version=2.63-soc_rev_22

OUR LAST PICK
*************************************************************************
Congratulations to all investors who took advantage of our last Stock
Pick!!!

GRYW - The stock was initially profiled at .40 cents and reached $1.80
in two weeks.

The situation with our new stock pick is similar so act now to get in
on the move!
*************************************************************************

++ Major Trading Alert : Late breaking news...++

******Investors have not yet had the opportunity to trade on this
information.******

After the close of trading on Friday, Kiwa biotech announced...

Three Orders in Q2 Represent an aggregate 700% Increase from
Distributors Previous Orders in Dollar Terms

LOS ANGELES, June 25, 2004 (PRIMEZONE) -- Kiwa Bio-Tech Products Group
Corporation (``the Company'' or ``KIWA'') (OTC BB:KWBT) announced today
that a China-based distributor of its products has placed its third
order this quarter, which represents a significant increase over the
previous order by this repeat customer. Entering Q2, the distributor placed
three orders which total 7 times the size of the order placed by this
customer in Q1.

******Investors have not yet had the opportunity to trade on this
information.******

The hottest stock Today - Watch KWBT

We expect some strong demand for this stock in the near future!!!!!

The Stock is EXTREMELY TIGHT - The float is only 4M shares!!!

Get on Board now and enjoy some great profits with KWBT

CURRENT PRICE - $.32

SPECULATIVE NEAR TERM TARGET PRICE - $.80
SPECULATIVE LONG TERM TARGET PRICE - $1.85

KWBT* KWBT* KWBT* KWBT* KWBT* KWBT* KWBT* KWBT* KWBT* KWBT * KWBT

About the Company:
------------------------------------------------------------------------
Based in the City of Industry, California, with manufacturing centers
in mainland China, KIWA Bio-Tech Products Group Corporation is a public
company (OTCBB: KWBT) that develops, manufactures and distributes
innovative, cost-effective, and environmentally-safe biotechnology products
to agricultural markets. The company is a pioneer in commercialization
of biotechnology, having a manufacturing base in Shandong Province,
China and plans to distribute bio-tech products worldwide.

With 20 years of research and development experience in biotechnology,
KIWA's patented products are produced through a cost-effective
manufacturing process. KIWA's first marketplace entry is Mainland China, with
an American presence planned by 2005. With approval and subsidies from
the Chinese government, KIWA has established a manufacturing center
which is a well developed distribution point for the world's most
populated country.

The Market:
-------------------------------------------------------------------------
KIWA Bio-Tech recognized early the dire need in mainland China for
affordable, easy-to-use organic agricultural products, as well as the
difficulties in distributing their products to farmers in the world's most
populous country. With over 1.3 billion people, China possesses 7% of
the world's agricultural land but supports 20% of the world's
population. With these demands the strain on arable land in China is enormous.
Overuse of chemical herbicides and insecticides hold the potential to
destroy the limited water supply of China, making organic compounds an
obvious alternative.

With China's underdeveloped farm communities, KIWA strives to provide
the average local farmer with the ability to grow higher quality produce
and greater crop yields. Agribusiness is 14% of China's Gross Domestic
Product, totaling as much as $180 billion in 2002 alone. With this type
of market potential, China was an obvious first choice for KIWA's
full-scale entry into the "Agri-Bio" marketplace. In the coming year an
entrance into the American agricultural market is planned, but KIWA will
establish the immense value of their product in Chinese agribusiness
first.

-------------------------------------------------------
We wish you profitable trading!!

---------------
Disclaimer
---------------
Information within this email contains "forward looking statements"
within the meaning of Section 27A of the Securities Act of 1933 and
Section 21B of the Securities Exchange Act of 1934. Any statements that
express or involve discussions with respect to predictions, goals,
expectations, beliefs, plans, projections, objectives, assumptions or future
events or performance are not statements of historical fact and may be
"forward looking statements."

Forward looking statements are based on expectations, estimates and
projections at the time the statements are made that involve a number of
risks and uncertainties which could cause actual results or events to
differ materially from those presently anticipated. Forward looking
statements in this action may be identified through the use of words such
as: "projects", "foresee", "expects", "estimates," "believes,"
"understands" "will," "part of: "anticipates," or that by statements indicating
certain actions "may," "could," or "might" occur. All information
provided within this email pertaining to investing, stocks, securities must
be understood as information provided and not investment advice.
Emerging Equity Alert advises all readers and subscribers to seek advice from
a registered professional securities representative before deciding to
trade in stocks featured within this email. None of the material within
this report shall be construed as any kind of investment advice. Please
have in mind that the inter retation of the writer of this newsletter
about the news published by the company does not represent the company
official statement and in fact may differ from the real meaning of what
the news release meant to say. Please read the news release by yourself
and judge by yourself about the details in it.

In compliance with Section 17(b), we disclose the holding of KWBT
shares prior to the publication of this report. Be aware of an inherent
conflict of interest resulting from such holdings due to our intent to
profit from the liquidation of these shares. Shares may be sold at any
time, even after positive statements have been made regarding the above
company. Since we own shares, there is an inherent conflict of interest in
our statements and opinions. Readers of this publication are cautioned
not to place undue reliance on forward-looking statements, which are
based on certain assumptions and expectations involving various risks and
uncertainties, that could cause results to differ materially from those
set forth in the forward- looking statements.

Please be advised that nothing within this email shall constitute a
solicitation or an offer to buy or sell any security mentioned herein.
This newsletter is neither a registered investment advisor nor affiliated
with any broker or dealer. All statements made are our express opinion
only and should be treated as such. We may own, buy and sell any
securities mentioned at any time. This report includes forward-looking
statements within the meaning of The Private Securities Litigation Reform Act
of 1995. These statements may include terms as "expect", "believe",
"may", "will", "move", "undervalued" and "intend" or similar terms. This
newsletter was paid $3,500 from third party to send this report. PLEASE
DO YOUR OWN DUE DILIGENCE BEFORE INVESTING IN ANY PROFILED COMPANY. You
may lose money from investing in Penny Stocks.


Index of Symbols Found

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34

Note that this number of occurrences may not match the number of occurrences of this symbol listed elsewhere in this database. This is because the symbol counts used elsewhere were generated with a more advanced algorithm that identified more symbols and also ignored identical segments of the same message.